Tianjin Pharmaceutical Da Rent Tang's (SGX:T14, SHA:600329) attributable profit to owners surged to 1.55 billion yuan during the second quarter of the year from 270.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.
Earnings per share rose to 2.01 yuan from 0.35 yuan in the comparable period.
Revenue declined 36% year over year to 1.20 billion yuan from 1.88 billion yuan, mainly due to a change in its consolidation scope.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.